© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Fresenius Medical Care AG & Co. KGaA (FMS) shows an Average True Range (ATR) of 0.36 and an Enterprise Value of 22.02B. Its average trading volume over the past 3 months is 404.18K, indicating liquidity. These fundamental metrics provide insight into FMS's underlying financial health and market activity.
Fresenius Medical Care AG & Co. KGaA (FMS) technical indicators as of December 24, 2025: the SMA 20 is 1.71%, SMA 50 at -2.62%, and SMA 200 at -6.89%. The RSI 14 value is 53.04, suggesting its current momentum. These technical analysis signals help assess FMS's price trends and potential future movements.
Fresenius Medical Care AG & Co. KGaA (FMS) stock performance overview as of December 24, 2025: The 52-week high is $30.46 (currently -21.34% below), and the 52-week low is $22.05 (currently 8.66% above). Over the past year, FMS's performance is 1.27%, compared to the S&P 500's 10.56% change.
According to market data, Fresenius Medical Care AG & Co. KGaA (FMS) stock's recent performance metrics show that over the last month, FMS is 6.06%, with a Year-to-Date (YTD) performance of 5.83%. Over the past year, the stock has seen a 1.27% change. These figures summarize FMS's price movements across various periods, reflecting its historical returns.
According to current financial data, FMS stock's P/E (TTM) ratio is 18.17, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for FMS, including P/S (0.61), P/B (0.90), and P/FCF (5.12), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.